Lixia Xu
Appearances
- DateMay 7, 2023BACKGROUND: Non-alcoholic steatohepatitis (NASH), a leading cause of liver-related morbidity and mortality, is highly prevalent in people living with HIV (PLWH).1 Microbial translocation (MT) associated with hepatic inflammation and fibrosis may play a critical role in NASH pathogenesis…
Presenter
Speakers
The Chinese University of Hong Kong - DateMay 8, 2023BACKGROUND: The LI-RADS (Liver Reporting and Data Systems) was created to standardize reporting of CT/MR imaging for liver masses in cirrhosis patients at risk of hepatocellular carcinoma (HCC)…
Presenter
Speakers
- DateMay 19, 2024BACKGROUND & AIMS: Gut microbiota plays an important regulatory role in tumor progression. Previous studies have shown that there are bacteria in hepatocellular carcinoma (HCC). However, the role of these bacteria in the development and progression of HCC remains unclear…
- DateMay 19, 2024BACKGROUND & AIM: About half of patients with hepatocellular carcinoma (HCC) are initially diagnosed with multi-nodule, which developed either from intrahepatic metastasis (IM) or multicentric occurrence (MO)…
Presenter
Speakers